Reviews

There are no reviews yet.

Be the first to review “Palivizumab Injection”

Your email address will not be published. Required fields are marked *

Description

(palivizumab)? SYNAGIS is a prescription medication that is injected (50 mg and 100 mg) in certain children to help prevent serious lung disease caused by respiratory syncytial virus (RSV). born prematurely (at or before 35 weeks) and who are 6 months old or younger at the beginning of RSV season.

Palivizumab Injection
Need Help?